Sequoia Financial Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.1K Buy
+32,285
New +$96.4K ﹤0.01% 2078
2026
Q1
Sell
-12,428
Closed -$44.9K 1929
2025
Q4
$44.9K Buy
12,428
+354
+3% +$1.54K ﹤0.01% 1900
2025
Q3
$45.5K Buy
+12,074
New +$46.6K ﹤0.01% 1719
2025
Q2
Sell
-10,155
Closed -$50.8K 1591
2025
Q1
$50.8K Sell
10,155
-3,500
-26% -$22.2K ﹤0.01% 1349
2024
Q4
$98.5K Buy
13,655
+3,500
+34% +$26.7K ﹤0.01% 1285
2024
Q3
$62.4K Hold
10,155
﹤0.01% 1248
2024
Q2
$67.5K Hold
10,155
﹤0.01% 1185
2024
Q1
$103K Buy
+10,155
New +$103K ﹤0.01% 1115

Other funds holding ALT

Sequoia Financial Advisors's ALT Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Altimmune (ALT) in Q2 2026: 32,285 shares worth $98.1K. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings. This is a return to the name: Sequoia Financial Advisors previously reported a position in ALT as recently as Q4 2025.

Sequoia Financial Advisors first reported a position in ALT in Q1 2024 and has held it in 8 quarters since. The position peaked at $103K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Sequoia Financial Advisors held 32,285 shares of Altimmune worth $98.1K as of Q2 2026.
  • Altimmune was a new Sequoia Financial Advisors position in Q2 2026.
  • Altimmune made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2078 holding.
  • Sequoia Financial Advisors first reported a position in Altimmune in Q1 2024 and has held it in 8 quarters since.
  • Sequoia Financial Advisors's Altimmune position peaked at $103K in Q1 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.